Apolipoprotein (apo)A I; Coronary heart disease (CHD); High density lipoproteins (HDL); Lipid lowering drugs; Low density lipoprotein (LDL)
Indexed keywords
ACETYLSALICYLIC ACID;
DILTIAZEM;
DNA;
EZETIMIBE;
FENOFIBRATE;
FISH OIL;
HIGH DENSITY LIPOPROTEIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
ISOSORBIDE;
METOPROLOL;
NICOTINIC ACID;
ROSUVASTATIN;
TRIACYLGLYCEROL;
ADULT;
ANALYSIS;
ARTICLE;
CASE REPORT;
CHOLESTEROL TRANSPORT;
DIET RESTRICTION;
DNA DETERMINATION;
GENE INSERTION;
GENE MUTATION;
GENE SEQUENCE;
HUMAN;
HYPOALPHALIPOPROTEINEMIA;
INFORMATION RETRIEVAL;
ISCHEMIC HEART DISEASE;
LUNG EXAMINATION;
MALE;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
TWO DIMENSIONAL ELECTROPHORESIS;
Small dense low density lipoprotein cholesterol and coronary heart disease: Results from the Framingham Offspring Study
M. Ai, S. Otokozawa, and B.F. Asztalos Small dense low density lipoprotein cholesterol and coronary heart disease: results from the Framingham Offspring Study Clin Chem 56 2010 967 976
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study
DOI 10.1161/01.ATV.0000146325.93749.a8
B.F. Asztalos, L.A. Cupples, S. Demissie, K.V. Horvath, M.C. Batista, and E.J. Schaefer High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants in the Framingham Offspring Study Arterioscler Thromb Vasc Biol 24 2004 2181 2187 (Pubitemid 39482449)
Role of LCAT in HDL remodeling: Investigation of LCAT deficiency states
DOI 10.1194/jlr.M600403-JLR200
B.F. Asztalos, E.J. Schaefer, and K.V. Horvath Role of LCAT in HDL remodeling: an investigation in LCAT deficiency states J Lipid Res 48 2007 592 599 (Pubitemid 46397462)
Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus
M. Ai, S. Otokozawa, and E.J. Schaefer Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus Clin Chim Acta 406 2009 71 74
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel
Expert Panel Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) J Am Med Assoc 285 2001 2486 2497
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Coordinating Committee of the National Cholesterol Education Program
S.M. Grundy, J.I. Cleeman, C.N. Merz Coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines J Am Coll Cardiol 44 3 2004 720 732
Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene
DOI 10.1006/bbrc.1993.2341
K. Nakata, K. Kobayashi, and H. Yanagi Autosomal dominant hypoalphalipoproteinemia due to A completely defective apolipoprotein A-1 gene Biochem Biophys Res Commun 196 1993 950 955 (Pubitemid 23337699)
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia
DOI 10.1016/j.atherosclerosis.2007.09.017, PII S0021915007005503
L. Pisciotta, T. Fasano, and L. Calabresi A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia Atherosclerosis 198 2008 145 151 (Pubitemid 351406362)
A cysteine-containing truncated Apo A-I variant associated with HDL deficiency
K. Moriyama, J. Sasaki, and Y. Takada A cysteine-containing truncated apoA-I variant associated with HDL Deficiency Arterioscler Thromb Vasc Biol 16 1996 1416 1423 (Pubitemid 26427593)
